Form 4: Vertiv Director Sells Over 200K Shares in Pre-Planned Trades

Sentiment:

Insider Transaction Report 2 March 2026 8:02 PM

Vertiv Holdings Co Director Roger Fradin executed pre-planned sales of over 200,000 Class A Common Stock shares from various grantor retained annuity trusts.

Worse than expectedThe sale of over 200,000 shares by a director, even if pre-planned, can be perceived as a negative signal by the market, potentially indicating that the insider believes the stock price is at a favorable level for selling.

Summary

Roger Fradin, a Director of Vertiv Holdings Co (VRT), reported sales of Class A Common Stock.
A total of 203,333 shares were sold across multiple transactions on February 26 and 27, 2026.
The sales were executed from various Grantor Retained Annuity Trusts (GRATs), specifically R VRT GRAT 2025, S VRT GRAT 2025, and R VRT GRAT 2024 II.
Sale prices ranged from a weighted average of $251.53 to $255.24 per share.
Following these transactions, Fradin's indirect beneficial ownership through GRATs stands at 151,626 shares.
The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating pre-scheduled sales.
Fradin continues to hold significant derivative securities, including stock options with exercise prices ranging from $11.50 to $85.04 and expiration dates up to March 7, 2035.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative signal due to the significant volume of shares sold by a director, despite the pre-planned nature of the transactions, which somewhat mitigates the negative impact.

Positives

The sales were conducted under a Rule 10b5-1(c) plan, suggesting they were pre-scheduled for estate planning or diversification rather than a reaction to new negative information.
The director retains significant indirect beneficial ownership of 151,626 shares through other GRATs, as well as substantial stock options, indicating continued alignment with shareholder interests.

Negatives

A director selling a substantial number of shares (over 200,000) could be perceived negatively by the market, potentially signaling a lack of confidence, even if pre-planned.
The sales occurred at relatively high share prices, which could be interpreted as the director taking profits.

Risks

Investor sentiment could be negatively impacted by the perception of insider selling, potentially leading to short-term share price volatility.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding Vertiv Holdings Co's future performance.

Industry Context

StockSavvy.ai notes that insider selling, even when pre-planned, can sometimes be viewed with caution by investors, especially in growth-oriented sectors where management confidence is a key driver. However, sales from GRATs are typically for personal estate planning and tax optimization, which often differentiates them from discretionary sales based on a change in company outlook. The data center infrastructure market, where Vertiv operates, continues to see strong demand, suggesting these sales are unlikely to reflect a negative shift in industry fundamentals.

Comparison to Industry Standards

Not directly applicable as this filing reports individual insider transactions rather than company performance metrics that can be benchmarked against industry peers or global standards. The prices at which shares were sold are specific to VRT's market valuation at the time of transaction.

Related Party Transactions

The transactions involved sales of shares held indirectly through Grantor Retained Annuity Trusts (GRATs), which are considered related party entities for estate planning purposes.

Stakeholder Impact

Shareholders may interpret the insider selling as a signal, potentially influencing their investment decisions and leading to short-term price fluctuations.
The transactions do not appear to have a direct impact on employees, customers, suppliers, or creditors.

Next Steps

The filing does not mention any specific future actions, events, or milestones for the company, beyond the scheduled vesting dates for the director's stock options.

Key Dates

Date	Description
02/07/2020	Grant date for 38,647 stock options with an exercise price of $12.05, vesting over four years.
02/04/2021	Grant date for 38,647 stock options with an exercise price of $20.56, vesting over four years.
03/03/2022	Grant date for 38,647 stock options with an exercise price of $11.50, vesting over four years.
03/07/2023	Grant date for 30,000 stock options with an exercise price of $15.84, vesting over four years.
03/07/2024	Grant date for 15,000 stock options with an exercise price of $72.09, vesting over four years.
03/07/2025	Grant date for 15,000 stock options with an exercise price of $85.04, vesting over four years.
02/26/2026	Date of multiple sales of Class A Common Stock from various GRATs.
02/27/2026	Date of multiple sales of Class A Common Stock from various GRATs.
03/02/2026	Signature date of the filing by Eric Boxterman, attorney-in-fact for Roger Fradin.
03/03/2026	Vesting date for 9,662 stock options granted on March 3, 2022.
03/15/2026	Vesting date for 7,500 stock options granted on March 7, 2023, 3,750 stock options granted on March 7, 2024, and 3,750 stock options granted on March 7, 2025.
03/15/2027	Future vesting date for stock options granted on March 7, 2023 and March 7, 2024.
03/15/2028	Future vesting date for stock options granted on March 7, 2024 and March 7, 2025.
03/15/2029	Future vesting date for stock options granted on March 7, 2025.
02/07/2030	Expiration date for stock options granted on February 7, 2020.
02/04/2031	Expiration date for stock options granted on February 4, 2021.
03/03/2032	Expiration date for stock options granted on March 3, 2022.
03/07/2033	Expiration date for stock options granted on March 7, 2023.
03/07/2034	Expiration date for stock options granted on March 7, 2024.
03/07/2035	Expiration date for stock options granted on March 7, 2025.

Recommendation

hold

While the significant insider selling could be a short-term negative sentiment driver, the transactions were pre-planned under a 10b5-1 plan, suggesting estate planning rather than a change in company fundamentals. The director also retains substantial equity and options. Investors should hold and monitor for further company-specific news or broader market trends affecting Vertiv, rather than reacting solely to this insider transaction.

Keywords

Vertiv Holdings Co, VRT, Form 4, Insider Selling, Roger Fradin, Director, Stock Sales, Class A Common Stock, GRAT, 10b5-1 Plan, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.